18. November 2009 03:17
Research and Markets (http://www.researchandmarkets.com/research/31c696/dealmaking_and_ind) has announced the addition of Decision Resources, Inc.'s new report "Dealmaking and Industry Outlook: Autoimmune and Inflammatory Diseases" to their offering.
[More]
17. November 2009 04:14
A seminar on Genetic Screening for Psoriatic Arthritis will be presented on Tuesday, December 8 from 12-1 PM Pacific Standard Time, hosted by pharmacogenomics research and development innovators PsoriasisDX, pioneers of the world’s first genetic test for psoriatic arthritis (PsA). The seminar will feature leading experts Dr. John Koo and Dr. Wilson Liao.
[More]
17. November 2009 03:42
Amid the mounting toll of budget cuts across the country, a new study from the National Coalition of STD Directors (NCSD) shows just how much an impact the economic crisis is having on sexually transmitted disease (STD) programs and in turn, having more broadly on public health infrastructure.
[More]
9022860f-aa77-4462-835a-e287aa11ea5f|0|.0
Posted in: Disease/Infection News | Healthcare News
Tags: Cancer, CDC, Cervical Cancer, Chlamydia, Gonorrhea, H1N1, Health Disparities, Health Reform, Infertility, Inflammatory Disease, Influenza, Pelvic Inflammatory Disease, Pregnancy, Syphilis, Tuberculosis
13. November 2009 00:54
A new analysis published by THE SAGE GROUP concludes that atherosclerotic peripheral arterial disease (PAD) afflicts over 20 million in India. Both PAD and CLI represent major and significantly underestimated problems for the Indian economy and healthcare system.
[More]
12. November 2009 10:44
Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, has announced that it has filed its first IND (investigational new drug) application with the U.S. Food and Drug Administration (FDA).
[More]
10. November 2009 07:56
Bristol-Myers Squibb Company and Alder Biopharmaceuticals, Inc., today announced a global agreement for the development and commercialization of ALD518, a novel biologic that has completed Phase IIa development for the treatment of rheumatoid arthritis.
[More]
cd62c559-1b13-404b-b80e-ee2576fff949|1|5.0
Posted in: Drug Trial News | Medical Condition News
Tags: Antibody, Anti-Inflammatory, Arthritis, Bone, Cancer, Education, Genetics, Immunology, Inflammatory Disease, Interleukin-6, Investment, Monoclonal Antibody, Rheumatoid Arthritis, Rheumatology
5. November 2009 01:59
A study at Johns Hopkins Children's Center found that girls diagnosed with pelvic inflammatory disease (PID) who watched a short educational video were three times more likely to discuss their condition with their partners and to ensure partner treatment than girls diagnosed and treated without seeing the film.
[More]
29. October 2009 00:37
Perhaps the most comprehensive, multi-institutional study yet of the sexually transmitted bacteria chlamydia is under way at the University of Maryland, Baltimore (UMB).
[More]
046eee0b-6336-41af-ab58-66be352204d3|0|.0
Posted in: Disease/Infection News
Tags: Allergy, Antibiotic, Chlamydia, Genomics, Gonorrhea, Hospital, Infertility, Inflammatory Disease, Pediatrics, Pelvic Inflammatory Disease, Vaccine
28. October 2009 06:38
Elan Corporation, plc and Biogen Idec today announced data showing that treatment with TYSABRI® (natalizumab) significantly reduced the rate of hospitalization compared with placebo in patients with moderate–to–severe Crohn’s disease during both induction and maintenance treatment.
[More]
37f914d0-c3c0-4ddf-8dab-9da7cd0ce5a3|0|.0
Posted in: Drug Trial News | Medical Condition News | Pharmaceutical News
Tags: Abdominal Pain, Antibody, Arthritis, Biotechnology, Brain, Crohn's Disease, Diarrhea, Gastroenterology, Headache, Hypersensitivity, Inflammatory Disease, Lymphoma, Multiple Sclerosis, Neuroscience, Rheumatoid Arthritis, Weight Loss
28. October 2009 05:36
October 29 is World Psoriasis Day. Conceived by patients for patients, World Psoriasis Day is a truly global event focusing on the burden of living with psoriasis. There are more than 125 million people with psoriasis/psoriatic arthritis in the world. Psoriasis is a severe chronic inflammatory disease that effects all ages, genders, races and ethnicities.
[More]
23. October 2009 01:49
Based on an extensive review of the highest quality scientific literature on psoriasis and the opinion of recognized psoriasis experts, the American Academy of Dermatology (Academy) has released new guidelines of care for the management and treatment of psoriasis with ultraviolet (UV) light therapy, also known as phototherapy. Recommendations for the use of the most common forms of UV light therapy, as stand-alone treatments or in conjunction with other therapies, were outlined, including patient considerations.
[More]
e9c66bc9-a85d-4bc6-86af-7207919fa4d7|0|.0
Posted in: Device / Technology News | Medical Condition News
Tags: Arthritis, Cancer, Cell, Dermatology, Education, Inflammatory Disease, Light Therapy, Lupus, Melanoma, Nausea, Pregnancy, Psoriasis, Psoriatic Arthritis, Skin Cancer, Squamous Cell Carcinoma, Vomiting, Xenon
22. October 2009 06:50
Research and Markets (http://www.researchandmarkets.com/research/7da76f/special_report_ca) has announced the addition of Decision Resources, Inc.'s new report "Special Report: Can Innovation Supplant Convention in Sarcoidosis Treatment?" to their offering.
[More]
22. October 2009 01:02
AutoImmune Inc. today announced that its Board of Directors has authorized the exploration of a full range of strategic alternatives available to the Company in order to enhance shareholder value. AutoImmune has retained Junewicz & Co. as its financial advisor for this evaluation process.
[More]
20. October 2009 05:35
Phase 3 data reported for the first time show that once every four week subcutaneous injections of SIMPONI(TM) (golimumab) resulted in significantly greater inhibition of structural damage compared with placebo plus methotrexate in patients with active rheumatoid arthritis (RA) and active psoriatic arthritis (PsA).
[More]
fecd05bb-f5de-4327-bddc-9855b00e1fef|0|.0
Posted in: Drug Trial News | Medical Condition News
Tags: Abatacept, Allergy, Ankylosing Spondylitis, Antibody, Arthritis, Basal Cell Carcinoma, Blood Pressure, Bone, Breast Cancer, Bronchitis, Cancer, Cartilage, Cell, Cold Sores, Cough, Diabetes, Diarrhea, Education, Golimumab, Heart Failure, Hepatitis B, Hodgkin's Disease, Immunology, Inflammatory Disease, Lung Cancer, Lupus, Lymphoma, Methotrexate, Monoclonal Antibody, Multiple Sclerosis, Nausea, Nephrology, Nervous System, Oncology, Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Rheumatology, Rituximab, Sepsis, Skin Cancer, Squamous Cell Carcinoma, TNF Blockers, Tuberculosis, Vaccine, Virus, Vomiting, Weight Loss
20. October 2009 05:27
Elan Corporation, plc and Biogen Idec today announced multiple presentations at the American College of Gastroenterology (ACG) Annual Scientific Meeting, taking place October 23-28 in San Diego.
[More]
e6581635-2195-4e0f-952f-551dc370ab2e|0|.0
Posted in: Drug Trial News | Disease/Infection News
Tags: Abdominal Pain, Arthritis, Biotechnology, Brain, Crohn's Disease, Diarrhea, Gastroenterology, Headache, Hypersensitivity, Inflammatory Bowel Disease, Inflammatory Disease, Lymphoma, Multiple Sclerosis, Neuroscience, Pregnancy, Rheumatoid Arthritis, Weight Loss
Subscribe